Related Experiment Videos
[7-Methyltryptophan9]-beta-corticotropin-(1-24): a hyperactive Synacthen analogue
International Journal of Peptide and Protein Research
|November 1, 1984
Summary
Researchers synthesized [7-Methyltryptophan9]-beta-corticotropin-(1-24), a novel compound. This new peptide demonstrated 2.7 times greater steroidogenic activity than standard beta-corticotropin-(1-24) in adrenal cell assays.
Area of Science:
- Biochemistry
- Endocrinology
- Peptide Chemistry
Background:
- Corticotropin-(1-24) (Synacthen) is a standard peptide hormone analog used in diagnostics.
- Understanding structure-activity relationships of corticotropin analogs is crucial for developing more potent or selective compounds.
Purpose of the Study:
- To synthesize a novel analog of beta-corticotropin-(1-24), specifically [7-Methyltryptophan9]-beta-corticotropin-(1-24).
- To evaluate and compare the steroidogenic activity of the synthesized analog against the parent compound.
Main Methods:
- Chemical synthesis of [7-Methyltryptophan9]-beta-corticotropin-(1-24).
- In vitro bioassay using isolated adrenal cells to measure steroidogenic activity.
Main Results:
- Successful synthesis of [7-Methyltryptophan9]-beta-corticotropin-(1-24).
- The synthesized analog exhibited 2.7-fold higher steroidogenic activity compared to beta-corticotropin-(1-24) (Synacthen).
Conclusions:
- [7-Methyltryptophan9]-beta-corticotropin-(1-24) represents a more potent analog of corticotropin.
- This finding contributes to the understanding of how specific amino acid substitutions affect the biological activity of corticotropin analogs.